Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,565 | -81,667 | -39,064 | -112,717 | -82,739 |
| Depreciation Amortization | 4,892 | 3,202 | 1,557 | 3,689 | 2,303 |
| Income taxes - deferred | 3,588 | -3,683 | -2,106 | -4,976 | -2,640 |
| Accounts receivable | 2,482 | 52,358 | 2,519 | -1,641 | 348 |
| Accounts payable and accrued liabilities | 3,835 | 21 | -2,001 | 2,561 | 4,931 |
| Other Working Capital | 81,675 | 50,346 | -16,951 | -2,026 | 3,661 |
| Other Operating Activity | 21,753 | -32,892 | 9,635 | 28,999 | 18,334 |
| Operating Cash Flow | $-13,340 | $-12,315 | $-46,411 | $-86,111 | $-55,802 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,878 | -2,376 | -2,099 | -18,987 | -17,539 |
| Investing Cash Flow | $-2,878 | $-2,376 | $-2,099 | $-18,987 | $-17,539 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 249,641 | 15,010 | 2,718 | 6,692 | 804 |
| Financing Cash Flow | $249,641 | $15,010 | $2,718 | $6,692 | $804 |
| Exchange Rate Effect | 57 | 960 | 453 | -1,120 | -4,674 |
| Beginning Cash Position | 339,154 | 339,154 | 339,154 | 438,680 | 438,680 |
| End Cash Position | 572,634 | 340,433 | 293,815 | 339,154 | 361,469 |
| Net Cash Flow | $233,480 | $1,279 | $-45,339 | $-99,526 | $-77,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,340 | -12,315 | -46,411 | -86,111 | -55,802 |
| Capital Expenditure | -2,878 | -2,376 | -2,099 | -18,987 | -17,539 |
| Free Cash Flow | -16,218 | -14,691 | -48,510 | -105,098 | -73,341 |